Weikang Bio-Technology Group (fka WKBT)

[pappy]

The ball is in the CEO's court even after some outstanding 2010 "audited" results followed up by a 1st qtr report that if true was about as good as it gets thanks to a strong backlog of new products that started entering the revenue stream in the 4th qtr of 2010.

Sure these new products along with effiencies of operation are increasing margins at a time when other TCM's are seeing margins decrease due to raw material increases.

But no one seems to care,today down volume is outpacing buy volume 21,918 shares vs 200 shares.

As far as im concerned as long as the numbers are legit. just keep up the outstanding job & once the fear in this space subsides wkbt will make a huge move to the upside.

However the CEO has a deadline to meet according to the terms of the private placement to get listed very soon or forfeit some of his shares placed in a make good account & the penalties continue until listing occurs.

At the present time the pps is far below the required listing pps & a reverse split would make the float to small as well.

So what will he do? Not much he can do presently accept continue the strong financial performance other than pay a small dividend.

Some of wkbt's funds are in the U.S. so this could be done without having to get permision from the Chinese government as long as the dividend was very small.

He could take wkbt private using some of that $60 million reported cash on hand & that would mean offering at least $2.00 per share for the 20% share count he doesn't already own which again is the reported cash per outstanding share.

It is very unusual to see a stock selling for less than the cash on hand but wkbt seems to be the exception to the rule with the pps fighting hard just to reach a buck.

This is telling me that while very few buyers currently exist someone is selling enough shares to hold the pps down & who could that be/